CINCINNATI, April 11, 2012 /PRNewswire/ -- Prasco Laboratories announced

Prasco Laboratories announced it is expanding its supply agreement with Shionogi Inc. Under the terms of the agreement, Prasco will market and distribute the Authorized Generic version of SULAR® (Nisoldipine) Extended Release Tablets in 8.5 mg, 17 mg, and 34 mg strengths in the U.S. under the Prasco label. The financial terms of the agreement were not disclosed.

Prasco® Laboratories announced today it has entered into an agreement with Shire (NASDAQ: SHPGY) for the distribution in the U.S. of the Authorized Generic version of Carbatrol® (Carbamazepine) Extended-Release Capsules in 100 mg, 200 mg and 300 mg strengths.

CINCINNATI, Dec. 6, 2011 /PRNewswire/ -- Prasco Chairman, Mr. E. Thomas Arington, announced today that Mr. Christopher H.

CINCINNATI, Oct.